Fresh Tracks Therapeutics

FRTX61

Penny Stock

$0.78arrow_drop_up5.40%$0.04

Penny Stock

FRTX61

$0.78

arrow_drop_up5.40%$0.04

Penny Stock

Performance History

Key Stats
Open	$0.74
Prev. Close	$0.74
EPS	-1.06
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$4.45M
PE Ratio	-

	LOW	HIGH
Day Range	0.74	0.78
52 Week Range	0.55	1.04

Ratios

Revenue	-





EPS	-1.06

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Fresh Tracks Therapeutics (FRTX)

Fresh Tracks Therapeutics Inc (FRTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of cancer. With a mission to improve the lives of patients, FRTX is dedicated to advancing the field of oncology by targeting specific genetic alterations that drive cancer growth. The company's novel approach involves the use of precision medicine and targeted therapies to inhibit the signaling pathways that promote tumor growth and progression.

One of the key factors driving FRTX's success is its pipeline of promising drug candidates. The company has several compounds in various stages of development, including both small molecules and biologics. These candidates have shown promising preclinical and early clinical data, with the potential to address significant unmet needs in the treatment of multiple cancer types.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Andrew D. Sklawer
Headquarters: Boulder
Employees: 13
Exchange: NASDAQ

add Fresh Tracks Therapeutics to watchlist

Keep an eye on Fresh Tracks Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Fresh Tracks Therapeutics 's (FRTX) price per share?

The current price per share for Fresh Tracks Therapeutics (FRTX) is $0.78. The stock has seen a price change of $0.04 recently, indicating a 5.41% change. This reflects the stock's recent market performance and investor sentiment.

help

Is Fresh Tracks Therapeutics (FRTX) a growth stock?

Fresh Tracks Therapeutics (FRTX) has shown an average price growth of 0.41% over the past three years. It has received a score of 13 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Fresh Tracks Therapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is the 52-week high and low for Fresh Tracks Therapeutics (FRTX)?

For Fresh Tracks Therapeutics (FRTX), the 52-week high is $1.04, which is 33.33% from the current price. The 52-week low is $0.55, the current price is 41.82% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

What is Fresh Tracks Therapeutics (FRTX) stock price performance year to date (YTD)?

As of the latest data, Fresh Tracks Therapeutics (FRTX) has a year-to-date price change of -13.33%. Over the past month, the stock has experienced a price change of -11.36%. Over the last three months, the change has been -16.61%. Over the past six months, the figure is -13.43%.

help

Is Fresh Tracks Therapeutics (FRTX) a profitable company?

Fresh Tracks Therapeutics (FRTX) has a net income of -$5.69M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -79.44% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 15.31%, providing insight into the company's sales performance and growth. The gross profit is $8.01M. Operating income is noted at -$6.36M. Furthermore, the EBITDA is -$6.32M.

help

What is the market capitalization of Fresh Tracks Therapeutics (FRTX)?

Fresh Tracks Therapeutics (FRTX) has a market capitalization of $4.45M. The average daily trading volume is 681, indicating the stock's liquidity and investor engagement.